Committee opinion no. 536: Human immunodeficiency virus and acquired immunodeficiency syndrome and women of color

Obstetrics and Gynecology

Volumn 120, Issue 3, 2012, Pages 735-739

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EMTRICITABINE; TENOFOVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN AMERICAN; CD4 LYMPHOCYTE COUNT; CONDOM; EDUCATION; HIGH RISK BEHAVIOR; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SAFE SEX; SEXUALITY; VIRUS TRANSMISSION; ARTICLE; ETHNOLOGY; FEMALE; PREVENTIVE HEALTH SERVICE; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICAN AMERICANS; ANTI-HIV AGENTS; FEMALE; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; PREVENTIVE HEALTH SERVICES; UNITED STATES;

EID: 84865650468     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31826dc477     Document Type: Review

References (35)

1. Centers for Disease Control and Prevention. Diagnoses of HIV infection and AIDS in the United States and dependent areas, 2010. HIV Surveillance Report. Atlanta (GA): CDC; 2012. Available at: http://www.cdc.gov/hiv/ surveillance/resources/reports/2010report/pdf/2010-HIV- Surveillance-Report-vol- 22.pdf. Retrieved June 1, 2012.
2. Centers for Disease Control and Prevention. HIV/AIDS and women. Available at: http://www.cdc.gov/hiv/topics/women/overview-partner.htm. Retrieved June 29, 2012.
3. Centers for Disease Control and Prevention. Diagnoses of HIV infection and AIDS among adolescents and young adults in the United States and 5 U.S. dependent areas, 2006-2009. HIV Surveillance Supplemental Report. Atlanta (GA): CDC; 2012. Available at: http://www.cdc.gov/hiv/surveillance/resources/reports/ 2009supp-vol17no2/pdf/hssr-vol-17-no-2.pdf. Retrieved June 1, 2012.
4. Espinoza L, Hall HI, Hardnett F, Selik RM, Ling Q, Lee LM. Characteristics of persons with heterosexually acquired HIV infection, United States 1999-2004. Am J Public Health 2007;97:144-9. (Pubitemid 46067696)
5. McFarland W, Chen S, Hsu L, Schwarcz S, Katz M. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. J Acquir Immune Defic Syndr 2003;33:96-103. (Pubitemid 36547247)
6. Centers for Disease Control and Prevention. HIV among women. Atlanta (GA): CDC; 2011. Available at: http://www. cdc.gov/hiv/topics/women/pdf/women. pdf. Retrieved June 1, 2012.
7. Hall HI, An Q, Hutchinson AB, Sansom S. Estimating the lifetime risk of a diagnosis of the HIV infection in 33 states, 2004-2005. J Acquir Immune Defic Syndr 2008;49:294-7.
8. Centers for Disease Control and Prevention. HIV among African Americans. Atlanta (GA): CDC; 2011. Available at: http://www.cdc.gov/hiv/topics/aa/PDF/aa. pdf. Retrieved June 1, 2012.
9. O'Leary A, Fisher HH, Purcell DW, Spikes PS, Gomez CA. Correlates of risk patterns and race/ethnicity among HIV-positive men who have sex with men. AIDS Behav 2007; 11:706-15. (Pubitemid 47327573)
10. Whyte Iv J. Sexual assertiveness in low-income African American women: unwanted sex, survival, and HIV risk. J Community Health Nurs 2006;23:235-44.
11. Forna FM, Fitzpatrick L, Adimora AA, McLellan-Lemal E, Leone P, Brooks JT, et al. A case-control study of factors associated with HIV infection among black women. J Natl Med Assoc 2006;98:1798-804. (Pubitemid 44885536)
12. Hallfors DD, Iritani BJ, Miller WC, Bauer DJ. Sexual and drug behavior patterns and HIV and STD racial disparities: the need for new directions. Am J Public Health 2007;97:125-32. (Pubitemid 46067694)
13. Winkler C, An P, O'Brien SJ. Patterns of ethnic diversity among the genes that influence AIDS. Hum Mol Genet 2004;13(Spec No 1):R9-19. (Pubitemid 38443795)
14. Harawa N, Adimora A. Incarceration, African Americans and HIV: advancing a research agenda. J Natl Med Assoc 2008;100:57-62.
15. Centers for Disease Control and Prevention. HIV among Latinos. Atlanta (GA): CDC; 2011. Available at: http://www. cdc.gov/hiv/resources/factsheets/pdf/ latino.pdf. Retrieved June 1, 2012.
16. Centers for Disease Control and Prevention. Compendium of evidence-based HIV behavioral interventions. Atlanta (GA): CDC; 2011. Available at: http://www.cdc.gov/hiv/topics/research/prs/compendium-evidence-based-inter- ventions.htm. Retrieved June 1, 2012
17. DiClemente RJ, Wingood GM, Harrington KF, Lang DL, Davies SL, Hook EW 3rd, et al. Efficacy of an HIV prevention intervention for African American adolescent girls: a randomized controlled trial. JAMA 2004;292:171-9. (Pubitemid 38917994)
18. Jemmott JB 3rd, Jemmott LS, Braverman PK, Fong GT. HIV/STD risk reduction interventions for African American and Latino adolescent girls at an adolescent medicine clinic: a randomized controlled trial. Arch Pediatr Adolesc Med 2005;159:440-9. (Pubitemid 40632133)
19. Mullen PD, Ramirez G, Strouse D, Hedges LV, Sogolow E. Meta-analysis of the effects of behavioral HIV prevention interventions on the sexual risk behavior of sexually experienced adolescents in controlled studies in the United States. J Acquir Immune Defic Syndr 2002;30(suppl 1):S94-105.
20. Salazar LF, DiClemente RJ, Wingood GM, Crosby RA, Harrington K, Davies S, et al. Self-concept and adolescents' refusal of unprotected sex: a test of mediating mechanisms among African American girls. Prev Sci 2004;5:137-49. (Pubitemid 39158489)
21. Jemmott LS, Jemmott JB 3rd, O'Leary A. Effects on sexual risk behavior and STD rate of brief HIV/STD prevention interventions for African American women in primary care settings. Am J Public Health 2007;97:1034-40. (Pubitemid 351181925)
22. Shain RN, Piper JM, Newton ER, Perdue ST, Ramos R, Champion JD, et al. A randomized, controlled trial of a behavioral intervention to prevent sexually transmitted disease among minority women. N Engl J Med 1999;340: 93-100. (Pubitemid 29054843)
23. Kamb ML, Fishbein M, Douglas JM Jr, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA 1998;280:1161-7. (Pubitemid 28457806)
24. Ehrhardt AA, Exner TM, Hoffman S, Silberman I, Leu CS, Miller S, et al. A gender-specific HIV/STD risk reduction intervention for women in a health care setting: short-and long-term results of a randomized clinical trial. AIDS Care 2002;14:147-61. (Pubitemid 34407277)
25. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. HPTN 052 Study Team. N Engl J Med 2011;365:493-505.
26. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vagas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. iPrEx Study Team. N Engl J Med 2010;363:2587-99.
27. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. The Partners PrEP Study Team. N Engl J Med 2012; DOI: 10.1056/NEJMoa1108524.
28. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexpo-sure prophylaxis for heterosexual HIV transmission in Botswana. The TDF2 Study Group. N Engl J Med 2012; DOI: 10.1056/ NEJMoa1110711.
29. FHI 360. FHI statement on the FEM-PrEP HIV prevention study. Durham (NC): FHI; 2011. Available at: http://www. fhi360.org/en/AboutFHI/Media/Releases/FEM- PrEP- statement041811.htm. Retrieved June 1, 2012.
30. Microbicide Trials Network. MTN statement on decision to discontinue use of oral tenofovir tablets in VOICE, a major HIV prevention study in women. Pittsburgh (PA): MTN; 2011. Available at: http://www.mtnstopshiv.org/node/3619. Retrieved June 1, 2012.
31. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. CAPRISA 004 Trial Group [published erratum appears in Science 2011;333:524]. Science 2010;329:1168-74.
32. Microbicide Trials Network. MTN statement on decision to discontinue use of tenofovir gel in VOICE, a major HIV prevention study in women. Pittsburgh (PA): MTN; 2011. Available at: http://www.mtnstopshiv.org/node/3909. Retrieved June 1, 2012.
33. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2011;60:65-8.
34. Gynecologic care for women with human immunodeficiency virus. Practice Bulletin No. 117 [published erratum appears in Obstet Gynecol 2011;117:412]. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;116:1492-509.
35. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep 2006;55:1-17; quiz CE1-4.